Data Collected Over 20 Years Demonstrates the Efficacy of the Treatment

Source: (1) “Use of Hapten Combined Cytotoxic Drugs for Enhancing Therapeutic Effect in Advanced Stages of Pancreatic Cancer,” Journal of Liver Research, Disorders & Therapy, December 30, 2015; (2) “Hapten Improved Overall Survival Benefit in Late Stages of Non-Small Cell Lung Cancer (NSCLC) by Ultra- Minimum Incision Personalized Intratumoral Chemo Immunotherapy (UMIPIC) Therapy With and without Radiation Therapy,” Journal of Cancer Prevention & Current Research, February 8, 2016; (3) Journal of Hepatocellular Carcinoma, 2015:2 1-12. (4) SEER data, based on compiled 2007-2013data